President Donald Trump is right that Americans pay too high a price for many pharmaceuticals. In a May 12 speech and signing ...

UnitedHealth Group investors, stunned by missteps at the once predictable healthcare giant, are warily expecting strategic ...

Biosimilars, too, are expected to gain ground as healthcare systems worldwide look for cost-effective alternatives to ...

New health data regulations promise to empower patients and help research, but can they overcome difficulties in ...

A new film from Eli Lilly sounds like a recruitment ad, but it doubles as a brand manifesto to showcase the pharmaceutical ...

Local pharmacists said current tariff policies will make drugs more expensive and harder to find for consumers.

Would the Trump administration's recently proposed drug pricing reforms hurt the biotech sector more than pharma? Seeking ...

Last year, Pirelli showed off its first 5G-connected Cyber Tyre. This year, it's taking that connectivity a step further.

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

The French drugmaker joined several peers in promising new investments in U.S. drug production, but cautioned plans could ...